Opinion
The European Union has decided to regulate overseas investment of sensitive technologies through its first-ever economic and security strategy.
It is interpreted that it has put the brakes on the outflow of technologies or products that can be diverted for military purposes to...
A series of ultra-high-priced gene treatments, including hemophilia treatments, which cost $3.5 million (about 4.4 billion won) per dose, are being released with approval...
According to the Wall Street Journal (WSJ), the U.S. and European health authorities have approved a total of four rare genetic disease treatments that...
